© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Busulfan stands out as a chemical compound that holds a significant role in the pharmaceutical and chemical industries. As a member of the alkyl sulfonate group, chemists and pharmacists recognize its unique molecular structure and practical uses. Busulfan’s formula, C6H14O6S2, outlines a compound with six carbon atoms, fourteen hydrogens, six oxygens, and two sulfur atoms. At first sight, the white, crystalline appearance offers some visual clues. Anyone who has handled it in a lab knows this solid can come in different forms: flakes, powder, small pearls, and pure crystals. Busulfan's density generally sits around 1.5 grams per cubic centimeter, showing a compact build — a key point for anyone considering its transport and storage.
In its raw state, busulfan appears as an odorless, almost tasteless solid. Handling this substance, the distinct texture comes through, whether as a fine powder or slightly larger crystal flakes. It boasts a melting point at approximately 103°C. Exposure to moisture gradually leads to decomposition, indicating the need for dry storage conditions. Few materials handle moisture so poorly. In my experience running quality control on active chemical ingredients, improper storage of similar compounds lowers yield and poses risks. Some raw materials come as powders to dissolve in solution, and busulfan requires careful handling to avoid losses. Often supplied in tightly sealed vessels, each batch comes with its own Certificate of Analysis, ensuring strict adherence to purity expectations.
The chemical backbone of busulfan, 1,4-butanediol dimethanesulfonate, reflects twin sulfonate groups hanging from a four-carbon chain. That arrangement underlies its strong alkylating ability—a property essential for its best-known use as a chemotherapy agent. The molecule’s reactivity, driven by the sulfonate esters, means it can act strongly on DNA, which helps treat illnesses but can threaten healthy cells. The HS Code for import/export typically falls under 2934999090. Regulatory agencies across the world keep a close eye on busulfan movements due to its dual status as a vital medicine and a hazardous chemical.
One should never ignore hands-on details. Each liter of a busulfan solution must be prepared with strict control. Solubility stands at about 1 mg per mL in water—very low—requiring researchers to use alcohol, dimethyl sulfoxide, or other solvents. Poorly dissolved busulfan can undermine experimental results, and in pharmaceutical manufacturing, that means batch recalls or wasted material. From my own work, temperature swings in storage rooms sometimes ruined sensitive raw materials like busulfan, causing chemical degradation even beneath tightly screwed caps. Proper labeling, secondary containment, and temperature controls save money and lives.
Anyone who works with busulfan appreciates the need for rigorous safety procedures. As a solid, powder, or in crystalline form, dust from mishandling can cause severe skin, eye, and respiratory irritation. The U.S. National Toxicology Program classifies it as carcinogenic—this isn’t just a theoretical risk. A slight spill, once airborne, can linger and affect a whole lab. Gloves, goggles, and sometimes respirators become routine gear, and no shortcut ever justifies the risk. Chemical waste disposal teams treat busulfan as hazardous waste, ensuring complete incineration under controlled conditions. In my years coordinating hazardous materials disposal, I saw several teams forced into temporary shutdown after minor exposures. No one working around pharmaceutical-grade chemicals underestimates regulatory compliance or the need for detailed personal protective equipment logs.
Supply chain disruptions have, on more than one occasion, forced pharmaceutical companies to scramble for reliable sources of busulfan. The manufacturing process for busulfan starts with essential raw materials like methanesulfonyl chloride and 1,4-butanediol, both vulnerable to global market swings and regulatory changes. I have seen firsthand how shortages in precursor chemicals slow production and drive up costs. Ensuring material integrity from the supplier through to the finished product calls for regular audits and laboratory purity tests. Inconsistent raw materials lead to failed quality checks, regulatory penalties, and wasted time. It only takes one substandard shipment to disrupt months of planning and affect patient outcomes for those relying on chemotherapy drugs.
Improvements can come from several directions. Tighter collaboration between raw material suppliers and pharmaceutical end users often results in better tracking, rapid issue resolution, and consistent delivery of compliant material. Emerging digital tracking systems—blockchain in chemical supply chains—offer new transparency and traceability, building on lessons learned from past disruptions. Periodic safety training that focuses on real-case incidents, not just theoretical hazards, brings critical awareness to lab teams. Specialized chemical storage, with automated temperature and humidity monitoring and secondary containment, cuts down on risk. Some manufacturers have started working with container companies to design custom packaging for sensitive chemicals like busulfan, reducing accidental releases and spoilage. Regulatory agencies in recent years have invested in outreach, helping smaller companies adopt hazardous-materials best practices. These steps enable safer and more reliable manufacture, shipping, and application of busulfan, keeping this vital compound available for both industrial and therapeutic use.
